Evidence map›Paper›PMID 18813792›Full record

ArticleInternational journal of oncology2008

Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.

Christopher S Gondi, Dzung H Dinh, Meena Gujrati, Jasti S Rao

Open access · bronzeAbstract read
In one paragraph

Article in International journal of oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. OWL-NETS: Transforming OWL Representations for Improved Network Inference.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2018
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher S GondiDepartment of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Dzung H Dinh
Meena Gujrati
Jasti S Rao
Peoria campus of the University of Illinois System · US

Funding

Cath B and uPAR si RNA constructs regressed glioma growthR01CA116708 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI O'BRYAN, JOHN P · 2005 to 2014
$2.9M
Inhibition of glioma tumor growth by antisense MMP-9R01NS047699 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2003 to 2011
$2.5M
Role of uPA and uPAR in Human Glioma InvasivenessR01CA075557 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI RAO, JASTI S. · 1998 to 2009
$2.3M
Growth inhibition of brain tumors by cord blood stem cellsR01NS057529 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2006 to 2010
$1.8M
Regression of meningioma tumor growth by combination therapyR01NS061835 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2008 to 2012
$1.7M
Role of TFPI-2 in human gliomas invasivenessR01CA095058 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2003 to 2007
$1.5M
Suppression of glioma invasion by a bicistronic constuctR01CA092393 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAO, JASTI S. · 2003 to 2007
$1.4M
NCI NIH HHS CA 116708NCI NIH HHS CA 75557NCI NIH HHS CA 92393NCI NIH HHS CA 95058NCI NIH HHS R01 CA075557NCI NIH HHS R01 CA092393NCI NIH HHS R01 CA095058NCI NIH HHS R01 CA116708NINDS NIH HHS NS057529NINDS NIH HHS NS47699NINDS NIH HHS NS61835NINDS NIH HHS R01 NS047699NINDS NIH HHS R01 NS057529NINDS NIH HHS R01 NS061835
6 · The paper itself

Abstract

We have previously demonstrated the effectiveness of simultaneous RNA interference (RNAi)-mediated downregulation of urokinase-type plasminogen activator receptor (uPAR) and matrix metalloproteinase-9 (MMP-9) in inhibiting tumor invasion in vitro and in vivo. In particular, we have shown that the downregulation of uPAR and MMP-9 inhibits intracranial tumor growth. The mechanism of the inhibition of tumor growth has not yet been determined. In this study, we have attempted to explain the mechanisms involved in the inhibition of invasiveness and tumor growth in vitro. SNB19 glioma cells were transfected with scrambled vector plasmid (pSV) and a siRNA-expressing plasmid targeting either uPAR (pU) or MMP-9 (pM) singly or in combination (pUM). Untransfected cells were also used as a control. Western blotting and RT-PCR analyses showed the downregulation of uPAR in pU-transfected cells and MMP-9 in pM-transfected cells. In cells transfected with pUM, we observed down-regulation of both uPAR and MMP-9, thereby indicating the specificity of the siRNA-expressing plasmids. An increase in caspase 9 expression was observed in cells transfected with pUM whereas no change in the level of caspase 9 was observed in pU or pM-transfected cells. Additionally, no change in the expression level of caspase 8 was observed. However, an increase in the expression level of cleaved PARP was observed in the case of cells transfected with pU, pM and pUM. Cells transfected with pUM showed the highest levels of cleaved PARP expression. Expression levels of APAF-1 were also higher in pUM-transfected cells with no change in expression levels of controls and in pU and pM-transfected cells. Total CAD expression levels did not change under any of the transfection conditions. However, immunohistochemical studies demonstrated that CAD was translocated to the nucleus, thereby indicating DNA damage. As determined by Western blot analysis of subcellular fractions, cytoplasmic levels of cytochrome c were also increased. We determined the extent of DNA damage using the TUNEL assay (poly-A termination of free -OH ends of degraded nuclear DNA). Based on our results we conclude that the simultaneous downregulation of uPAR and MMP-9 induces apoptosome-mediated apoptosis.

Indexed as

ApoptosisGene Expression Regulation, NeoplasticBrain NeoplasmsCaspase 9CytosolDNA FragmentationEnzyme ActivationFas-Associated Death Domain ProteinGliomaHumansMatrix Metalloproteinase 9MitochondriaModels, BiologicalReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorCaspase 9FADD protein, humanFas-Associated Death Domain ProteinMatrix Metalloproteinase 9PLAUR protein, humanReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorRIPK1 protein, human

Identifiers

PMID18813792
PMCPMC2562615
OpenAlexW2103397774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.